Quarter [qnco]
century [phsu, vita]
Drug [phsu]
treatment [ftcn]
Dyslipoproteinemia [patf]
Focus [spco]
HMG-CoA reductase inhibitor [orch, phsu]
fluvastatin [orch, phsu]
Disorders [dsyn]
Delayed [tmco]
Clearance [qlco]
Beta very low density lipoprotein [aapp, bacs, lipd]
Low density lipoprotein [aapp, bacs, lipd]
Coronary artery disease, premature [fndg]
Five [qnco]
Class [inpr]
Low density lipoprotein [aapp, bacs, lipd]
lowering [spco]
Drugs [phsu]
ACT [topp]
Basic [ftcn]
Mechanisms [ftcn]
Increased [qnco]
Predictability [menp]
Safety [hcpp]
Efficacy [qlco]
Lipid lowering agents [phsu]
allowed [socb]
Controlled Clinical Trial [inpr]
Reducing [qlco]
Low density lipoprotein [aapp, bacs, lipd]
???lead [elii, hops]
reduction [npop]
coronary artery disease [dsyn]
fluvastatin [orch, phsu]
Completely [qlco]
Targeted [ftcn]
Secreted [celf]
Bile [bdsu]
Active [ftcn]
Circulating [ftcn]
Metabolites [bacs]
Safety [hcpp]
Efficacy [qlco]
fluvastatin [orch, phsu]
Subject [grup]
treated [topp]
United States [geoa]
Canada [geoa]
Europe [geoa]
treated [topp]
Combination [qlco]
fluvastatin [orch, phsu]
Cholestyramine [orch, phsu]
Additional [ftcn]
Cholesterol [bacs, strd]
lowering [spco]
Lipoprotein [aapp, bacs]
Coronary Atherosclerosis [dsyn]
Study [mnob]
randomized [resa]
DOUBLE BLIND [resa]
Trial [resa]
fluvastatin [orch, phsu]
Quantitative [qnco]
Coronary angiography [diap]
Measure [qnco]
Plaque, Atherosclerotic [bdsu]
Positron-Emission Tomography [diap]
Evaluate [ftcn]
Myocardial perfusion [orga]
Myocardial [spco]
Reserve [acty]
Exploration [topp]
Lipoproteins [aapp, bacs]
Atherogenesis [patf]
Make [ftcn]
Availability [ftcn]
Generation [tmco]
Cholesterol [bacs, strd]
lowering [spco]
Agent [chvf]
